CompletedNot Applicable

Improvement Adherence to Clinical Practice Guidelines Using the Clinical Decision Support System in Patients With Hypertension and Atrial Fibrillation

Russia282 participantsStarted 2022-05-17

Plain-language summary

The Clinical Decision Support Systems (CDSS) based on real clinical data and its own algorithms can help to make the right choice according to guidelines. The goal of the INTELLECT II study is to investigate treatment adherence to guidelines/science-based medicine and its impact on patient outcomes into two groups of doctors, clinical centers with standard care of treatment (control), and clinical centers using CDSS (active).

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \> 18 years old * Patients diagnosed with nonvalvular atrial fibrillation and hypertension and indications for therapy according to European guidelines. Exclusion Criteria: * Inability to adhere to study procedures * Severe heart-valve disorder * Stroke within 14 days or severe stroke within 6 months before screening * Active bleedings * Thyroid dysfunction * Pregnancy * Secondary hypertension

What they're measuring

Compliance with AF/hypertension clinical practice guidelines

Timeframe: 1 month

Trial details

NCT IDNCT05367141

SponsorSamara Regional Cardiology Dispensary

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12-24

View on ClinicalTrials.gov More Atrial Fibrillation trials